https://www.avient.com/news/halal-certification-expands-avient-s-colorants-and-additives-produced-indonesia-site
Beyond food and beverages, drugs, cosmetics, and any other consumer goods used or applied by humans, the regulation extends to manufacturing processes and the compliance of packaging products.
https://www.avient.com/news/avient-expands-resound-tpe-portfolio-new-grade-formulated-fda-reviewed-post-consumer-recycled-material
Food and Drug Administration (FDA).
https://www.avient.com/idea/medical-stoppers-improved
Coring refers to the tiny fragments of material sheared off by the needle as it penetrates the stopper or septum, which could potentially contaminate the drug inside the container.
https://www.avient.com/sites/default/files/2024-09/Colorant Chromatics Brochure_2024.pdf
OUR CUSTOMER SUPPORT ACTIVITIES INCLUDE:
• Food and Drug Administration (FDA) compliance support
• Compliance with National Inventories
• Biocompatibility compliance
• REACH – European Legislation on Registration, Evaluation,
Authorization and Restriction of Chemicals
• Restriction on Hazardous Substances (RoHS) and Waste Electrical
and Electronic Equipment (WEEE) electronics compliance
• Data entry into the International Material Database System (IMDS)
• Hazardous communication, including safety data sheets (SDS)
and labeling
GENERATING REGULATORY COMPLIANCE
DOCUMENTATION INCLUDING:
• California Proposition 65
• European Food Contact
• Individual Customer Restricted Substance lists
• Drug Master Files
• Medical Application Files
• Food and Drug Administration Certification
• Potable Water Certification
Contact us if you have questions or for specific information
on your application’s regulatory compliance requirements.
https://www.avient.com/sites/default/files/2020-07/phthalate-facts-brochure.pdf
PHTHALATES FACTS
PHTHALATES ARE KNOWN
TO BREAK DOWN IN THE
HUMAN BODY
Research has shown that after
entering the body, phthalate
are broken down into metabolites
within minutes and pass out
quickly in urine.2
PHTHALATE EXPOSURE
IS CONSIDERED LOW
Despite the fact that phthalates
are used in a wide range of
products, human exposure from
all sources is considered to be
extremely low.2
PHTHALATES ARE A USEFUL
CHOICE FOR HEALTHCARE
Flexible vinyl tubing does not
react with most medications,
allowing for reliable
administration of drugs, while
flexible vinyl bags prevent blood
contamination and extend shelf
life of the blood.3
PHTHALATES ARE
REGULATED
Based on earlier studies, a few
specific phthalates have been
banned for use in toys or other
items for sale to children
under twelve to reduce risk of
overexposure through hand-to-
mouth behaviors.
1 Source: chemicalsafetyfacts.org 2 Source: Centers for Disease Control and Prevention 3 Source: thisisplastics.com
www.avient.com
Copyright © 2020, Avient Corporation.
https://www.avient.com/sites/default/files/2022-12/Mevopur Healthcare Bio-based Polymer Solutions Application Bulletin.pdf
KEY CHARACTERISTICS
• Available for polyethylene, polypropylene, ABS,
polycarbonate and styrenics
• Bio-content of resin carrier varies from 70% to
100% depending on polymer—calculated to
ASTM D6866 standard
• Manufactured at four ISO 13485 certified sites,
providing global consistency and security of
supply
• Documented change control beyond CAS
number, reducing risk of change
• Drop-in solutions that can be processed like
fossil-based grades on common injection
molding and extrusion machines
• Can be provided as ready-to-use pre-colored
or additive formulation
REGULATORY SUPPORT
• Raw materials tested to:
- ISO 10993-1
- USP and (incl. class VI)
- European Pharmacopeia, monograph 3.1.3/
3.1.5 (polyolefin packaging materials)
- USP (polyethylene)
- Elemental impurities as per ICH Q3D
• Registered Drug Master File (Type III) and/or
Device Master File
• Food contact according to US FDA and
APPLICATION BULLETIN
Sustainability Spotlight
Bio-polymers
Healthcare use limitations apply—see below.
https://www.avient.com/sites/default/files/2023-01/Mevopur Healthcare Functional Additives for Bormed Resins Application Bulletin.pdf
MEVOPUR COLORANTS
• Standard colors in PP and PE to shorten
time-to-market
• Custom colors matched to Pantone, RAL or
other color reference
• White colorants for pharmaceutical packaging
for LDPE, HDPE and PP with opacity to reach
USP chapter
MEVOPUR FUNCTIONAL ADDITIVES
• Antistatic formulation with good flow/impact
for injection molding
• Amide- and amine-free antistatic for film
in contact with API (Active Pharmaceutical
Ingredients)
• UV blocking for transparent PP and PE
packaging to meet USP chapter
• Non-migrating friction reduction/processing
aid for PE and PP
• Laser marking/welding additive for fast,
reliable marking/assembly
• MVTR (Moisture Vapor Transmission Rate)
reduction for HDPE to improve shelf-life
• Thermal protection of the polymer during
processing
• Gamma/e-beam sterilization protection for
PP (up to 50kGy) with color compensation
for reduced yellowing
REGULATORY SUPPORT
• Raw materials tested to:
- ISO 10993-1 and USP biological
evaluation
- European Pharmacopeia 3.1.3/3.1.5
(polyolefin)
- USP (polyethylene)
- ICH Q3D elemental impurities
• Registered Drug Master File (Type III) and/or
Device Master File
• Food contact established with FDA/EU*
APPLICATION BULLETIN
* FDA/EU compliance information available upon request
Bormed™ is a registered trademark of Borealis
Healthcare use limitations apply—see below.
https://www.avient.com/sites/default/files/2023-05/Mevopur Healthcare Colorants and Formulations Amber for Pharma Application Bulletin.pdf
KEY CHARACTERISTICS
• Manufactured at four ISO 13485 certified sites,
providing global consistency and increased
security of supply
• Documented change control beyond CAS
number level, reducing risk of change
• Non-phthalate and formulated without
animal-derived substances
• Different tones of amber available on request
—more or less red or yellow and/or lighter
or darker
• Also available in liquid form
REGULATORY SUPPORT
• Pre-tested raw materials:
- ISO 10993-1 and USP parts
(Class VI)
- European Pharmacopeia, monograph
3.1.15, USP and elemental analysis
as per ICH Q3D
- USP criteria appearance of solution,
color
• Registered Drug Master File (Type III) by
the FDA
• Food contact compliance established with
FDA/EU*
• YBB00102002-2015 (oral liquid pharmaceutical
PET bottles) compliance support
APPLICATION BULLETIN
* FDA/EU compliance
information available
upon request
Healthcare use limitations apply—see below.
https://www.avient.com/sites/default/files/2020-09/oncap-hc-product-bulletin.pdf
KEY CHARACTERISTICS
• Formulated specifically for healthcare product
applications
• Wide portfolio of polymer additive solutions,
including:
- Antimicrobial technology
- Surface energy modification, including
low retention
- Authentication technology
- Lasermarking
- Sterilization and content protection
- Processing optimization
- FDA compliant resin and color changeover
solutions
• OnCap HC Plus certified for USP Class VI and ISO
10993 bio-compatibility requirements; includes
anti-oxidant, lasermarking, antimicrobial,
radiopacifier, anti-stat, and polymer and
gamma stabilization performance additives
OnCap™ HC & OnCap™ HC Plus
Additives for Healthcare
PRODUCT BULLETIN
INDUSTRY SUPPORT
• Supported with a broad range of technical support
and services:
- Restricted medical-grade raw material
selection process
- Sampling program
- World-class FDA cGMP manufacturing facilities
- Batch traceability and formulation
lockdown systems
- FDA Drug Master Files or Medical Device
Files maintenance
MARKETS AND APPLICATIONS
OnCap HC and OnCap HC Plus Additives are an
excellent choice for medical devices and parts,
pharmaceutical or cosmetic packaging, and many other
healthcare related polymer applications.
https://www.avient.com/sites/default/files/2024-03/Terms and Conditions of Sale for Luxembourg.pdf
Terms Adjustment; Delivery.
Seller may change the price and/or
terms of delivery and shipment at any time up until delivery,
except where a written alternative pricing mechanism exists that
is signed by Seller.
Unless Seller and Buyer have expressly agreed to a firm delivery
date term in a single writing signed by both parties, delay in
delivery of any Products shall not relieve Buyer of its obligation
to accept delivery thereof.